PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?

Triple negative breast cancer (TNBC) has an aggressive clinical behaviour, with a poorer prognosis compared to other subtypes. Recently, tumor-infiltrating lymphocytes (TILs) have been proposed as a predictive biomarker for a better clinical outcome and pathological response (pR) after neoadjuvant c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerbelli, Bruna, Pernazza, Angelina, Botticelli, Andrea, Fortunato, Lucio, Monti, Massimo, Sciattella, Paolo, Campagna, Domenico, Mazzuca, Federica, Mauri, Maria, Naso, Giuseppe, Marchetti, Paolo, d'Amati, Giulia, Costarelli, Leopoldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745649/
https://www.ncbi.nlm.nih.gov/pubmed/29387716
http://dx.doi.org/10.1155/2017/1750925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745649/
https://www.ncbi.nlm.nih.gov/pubmed/29387716
http://dx.doi.org/10.1155/2017/1750925

Ejemplares similares